A Study of Galcanezumab in Healthy Participants.
Clinical trial NCT02836613 · COMPLETED
Trial details
- NCT number
- NCT02836613
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-02-27
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.